Apes Apes City BETA
Apes Apes BETA
NASDAQ S&P 500 DOW AAPL NVDA TSLA MSFT GOOGL META AMZN BTC ETH GOLD SILVER PLATINUM NASDAQ S&P 500 DOW AAPL NVDA TSLA MSFT GOOGL META AMZN BTC ETH GOLD SILVER PLATINUM
HLN Dados de participação institucional 13F Análise da ação
Sem dados de participação institucional
Informações da empresa Healthcare Drug Manufacturers - Specialty & Generic
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Liquidez corrente (TTM)
-
Dívida / Patrimônio (TTM)
-
País
GB
Sem dados de tendência trimestral
Notícias relacionadas a HLN